The importance of VTE prevention after orthopaedic surgery.
Becker
Richard C
RC
Duke University School of Medicine, Duke Clinical Research Institute, Durham, NC 27705, USA. richard.becker@duke.edu
D000925:Anticoagulants / Q000627:therapeutic use; D017281:Cost of Illness; D017984:Enoxaparin / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006801:Humans; D007902:Length of Stay; D009025:Morpholines / Q000627:therapeutic use; D019637:Orthopedic Procedures / Q000009:adverse effects*; D040242:Risk Reduction Behavior; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use; D054556:Venous Thromboembolism / Q000191:economics / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D017984:Enoxaparin; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban